Yokohama, Japan

Yukari Fujimoto

This inventor holds 1 USPTO granted patent. Top assignees: Keio University, Regimmune Corporation. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukari Fujimoto. Retrieved from https://idiyas.com/inventor/yukari-fujimoto-v01bza0x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Yukari Fujimoto

Introduction

Yukari Fujimoto is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the activation of natural killer T cells. His work focuses on developing novel compounds that can enhance immune responses.

Latest Patents

Yukari Fujimoto holds a patent for a compound or salt thereof that acts as a natural killer T cell activator. The patent addresses the need for a new compound capable of activating these cells, which play a crucial role in the immune system. The invention includes a pharmaceutical composition that incorporates this compound, providing a potential therapeutic avenue for various diseases.

Career Highlights

Throughout his career, Yukari Fujimoto has worked with prestigious institutions, including Keio University and Regimmune Corporation. His research has contributed to advancements in immunology and therapeutic development.

Collaborations

Yukari has collaborated with notable colleagues such as Junichiro Kishi and Natsumi Hirata, who have also contributed to the field of immunology.

Conclusion

Yukari Fujimoto's innovative work in developing natural killer T cell activators showcases his commitment to advancing medical science. His contributions have the potential to impact therapeutic strategies significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…